OICR leadership

Laszlo Radvanyi

Laszlo Radvanyi

President and Scientific Director

More details  →

Christine Williams

Deputy Director Interim Head, Clinical Translation

More details

Michele Noble

Executive Advisor

More details

Lincoln Stein

Head, Adaptive Oncology

More details

Jeanette Dias D'Souza

Chief Financial Officer

More details

Board of Directors

Tom Closson

Chair Principal, Tom Closson Consulting

More details  →

John Capone, PhD

VP Research, Western University

More details  →

Sharon M. Chandler

Member-at-Large, Canadian Cancer Society Ontario Board

More details

Roger Deeley, PhD

President, KGHRI and Vice President Health Sciences Research, Kingston General Hospital

More details  →

Dennis Giokas

President of Theoria Health Innovations Inc. 

More details  →

Wendy Kelley

Principal, Kelley Law 

More details  →

Ken Lawless

President and CEO, Epitope Capital Corp. & CEO, BioDiesel Reactor Technologies Inc.

More details  →

Morag Park, PhD

Director, Rosalind and Morris Goodman Cancer Research Centre

More details  →

Geoffrey Porter, MD

Professor of Surgery, Ramia Chair in Surgical Oncology, Dalhousie University

More details  →

Michael Sherar, PhD

President and CEO, Cancer Care Ontario

More details  →

Bradly G. Wouters, BEng, PhD

Executive Vice-President, Science and Research, University Health Network

 

Scientific Advisory Board

Todd R. Golub, MD (co-Chair)
  • Core Institute Member, Chief Scientific Officer and Director of the Cancer Program Broad Institute
Richard L. Schilsky, MD, FASCO (co-Chair)
  • Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology
François Bénard, MD
  • Professor and BC Leadership Chair in Functional Cancer Imaging, Department of Radiology, University of British Columbia
  • Vice President Research, BC Cancer Agency
Patricia Ganz, MD
  • Distinguished University Professor, Prevention & Control Research, UCLA Fielding School of Public Health, David Geffen School of Medicine at UCLA
  • Director, Cancer Jonsson Comprehensive Cancer Center, Los Angeles, California
Elaine R. Mardis, PhD
  • Nationwide Foundation Endowed Chair in Genomic Medicine
  • Co-Executive Director, Institute for Genomic Medicine at Nationwide Children's Hospital
  • Professor of Pediatrics, The Ohio State University College of Medicine
Michael J. Morin, PhD
  • President and CEO, Immunome, Inc.
Dennis Sgroi, MD
  • Executive Vice Chair Department of Pathology, Massachusetts General Hospital
  • Professor of Pathology, Harvard Medical School